William R. Jarnagin
0000-0002-1635-5768
Publication & Citation Trends
Publications
0 total
Automated Radiomics Model for Preoperative Pancreatic Neuroendocrine Tumor Grade Prediction.
Cited by 0
Semantic Scholar
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial
Cited by 0
Semantic Scholar
The Margin of the Largest Tumor Predicts Overall Survival After Resection of Multitumor Colorectal Liver Metastases
Cited by 0
Semantic Scholar
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial
Cited by 0
Semantic Scholar
377: LARGE LANGUAGE MODELS ENABLE ACCURATE DATA EXTRACTION AND CURATION FROM SYNOPTIC RADIOLOGY REPORTS FOR PANCREATIC CYST SURVEILLANCE
Cited by 0
Semantic Scholar
Abstract 724: Target identification for antibody-drug-conjugate (ADC) therapy in biliary tract cancers (BTC)
Cited by 0
Semantic Scholar
Multimodal machine learning models enhance outcome prediction in intrahepatic cholangiocarcinoma
Cited by 0
Semantic Scholar
Research Topics
Cholangiocarcinoma and Gallbladder Cancer Studies
(438)
Pancreatic and Hepatic Oncology Research
(388)
Hepatocellular Carcinoma Treatment and Prognosis
(375)
Gallbladder and Bile Duct Disorders
(166)
Colorectal Cancer Treatments and Studies
(145)
Affiliations
Northwestern University
Roche (Switzerland)
Rush University Medical Center
San Francisco General Hospital
National Institutes of Health